© 2018 by FirstScan™

  • White Facebook Icon
  • White Twitter Icon

FirstScan™ is the only independent facility in the region accredited by the ACR for Body imaging 

We are also accredited for MSK, Spine, and Head imaging

NeuroQuant® Volumetric Brain MRI

FirstScan™ is proud to be the first independent imaging facility in Omaha to offer NeuroQuant® volumetric brain MRI imaging. As an adjunctive screening with Neuro MRI, NeuroQuant® provides physicians, researchers, and patients an innovative way to quantify brain atrophy and assess neurogenerative diseases. This FDA-approved software tool provides physicians with objective data to identify and assess neurodegeneration in the earliest stages to help determine the clinical treatment course, while supporting patients in healthy lifestyle planning.

 

NeuroQuant® supports the diagnosis, assessment, and monitoring of neurogenerative diseases such as:

 

  • Dementia

  • Alzheimer’s Disease

  • Traumatic Brain Injury (TBI)

  • Multiple Sclerosis

  • Epilepsy, among others

‚Äč

Why Choose Adjunctive Screening With NeuroQuant®

 

In the case of many neurological diseases, the disease progression is accompanied by regional or generalized brain volume loss. Using NeuroQuant®, FirstScan™ can non-invasively measure, quantify, and localize the loss of volume.  With NeuroQuantÒadjunctive screening, there five reports that can be customized to the needs of the patient including:

 

  • Age-Related Atrophy:  The Age-Related Atrophy Report supports physician assessment of cognitive impairment and memory loss. It provides quantitative measurements of neurodegeneration of both the hippocampus and inferior lateral ventricles for evaluation of neurodementias. 

 

  • Hippocampal Asymmetry: The Hippocampal Asymmetry Report uses the absolute and relative volumes of the right and left hippocampus, measuring any asymmetry between the two. This helps physicians asses temporal lobe epilepsy and unilateral degenerative conditions. 

 

  • Multi Structure Atrophy: Using nine different brain structures, the Multi Structure Atrophy Report supports the assessment and monitoring of neurodegenerative diseases like Multiple Sclerosis. 

 

  • Triage Brain Atrophy: The Triage Brain Atrophy Report provides a reference point on regional and global brain structure volumes to help in the assessment of TBI and neurodegenerative disease.

 

  • Brain Development: The Brain Development report was developed for children ages 3 and up to provide information on the volume of the forebrain parenchyma and lateral ventricles. 

 

How NeuroQuant® Works

 

NeuroQuant® starts with a MRI brain scan. The data collected is sent to a HIPAA-protected server, where the NeuroQuant® software automatically identifies and segments multiple brain structures. The volume of these segments are measures and compared to a normative database adjusted for age, gender, and cranial volume. This this data, NeuroQuant® then generates a customized report to provide both visual and quantitative information for the Radiologist and your physician. These reports will be used by your physician to guide their treatment program.